Press Releases from Respiratory Syncytial Virus Drugs (1 total)
Global Human Respiratory Syncytial Virus Drugs Market to grow at a CAGR of 4.27% …
About Human Respiratory Syncytial Virus Drugs
Respiratory syncytial virus (RSV) is a virus that leads to infections in the lungs and the respiratory tract. It commonly affects most children in the ages 2 or below. RSV can also infect adults. In adults and the older population, the symptoms of RSV are mild and similar to that of common cold. Infection with RSV can be severe in certain cases, particularly in premature…
